Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Safe Orthopaedics
  6. News
  7. Summary
    ALSAF   FR0013467123


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Safe Orthopaedics : Medical inaugurates its Integrated Innovation and Production Centre (CIPI) on the Fleurieux-sur-l'Arbresle (69) industrial site

10/13/2021 | 12:02pm EDT


Safe Medical inaugurates its Integrated

Innovation and Production Centre (CIPI) on the

Fleurieux-sur-l'Arbresle (69) industrial site

  • A titanium 3D printing module and a clean room dedicated to packaging complete the existing facilities
  • 2.5M€ have been invested in the Safe Medical site since its acquisition by Safe Orthopaedics in 2020
  • A leading industrial complex in Europe for the innovation and production of orthopedic surgery medical devices

Éragny-sur-Oise, Fleurieux-sur-l'Arbresle,October 13, 2021 at 5:45 pm CET - Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly safe for emergency-treated vertebral fractures, has announced the inauguration of its Center for Innovation and Integrated Production (CIPI), on the Fleurieux-sur-l'Arbresle (69) industrial site. Operational since September, the CIPI includes two clean rooms dedicated to the packaging of medical devices and a titanium 3D printing module for the design of implants and surgical tools. It complements the production lines and the R&D unit set up in 2020 and entirely dedicated to orthopedic surgery.

Safe Orthopaedics acquired Safe Medical (Ex-LCI Medical) in 2020. Since then, the company has invested €2.5 million in the Fleurieux-sur-l'Arbresle site, making it a leading industrial complex in Europe for the innovation and production of medical devices for orthopedic surgery. One million euros were devoted to the renovation and extension of the buildings, and nearly 1.5 million to the technological re-equipment of the site (1.5 million euros). The Safe Group received support from Bpifrance for this project, via a €0.8 million innovation loan.

The activity of the Safe Medical site is driven by the recovery of the subcontracting activity, with volumes now higher than their pre-crisis level, and by the internationalisation of the production of Safe Orthopaedics' proprietary innovations.

Pierre Dumouchel, Chairman and CEO of Safe Orthopaedics, said: "We are delighted that our Integrated Innovation and Production Centre (CIPI) is now up and running, in line with the timetable we set ourselves a year ago when we launched the work. The integration of the entire value chain, from R&D to manufacturing, on the same site allows us to streamline our processes, with an economic and environmental impact, while also giving us the means to radically accelerate the innovation cycle. We will continue to invest in the Fleurieux-sur- l'Arbresle site to maintain the excellence of this industrial site and ensure our leadership in spine surgery."


About Safe Group

Safe Group is a French medical technology group that brings together Safe Orthopaedics, a pioneer in ready-to-use technologies for spine pathologies, and Safe Medical (formerly LCI Medical), a subcontractor of medical devices for orthopedic surgery. The group employs approximately 150 people.

Safe Orthopaedics develops and manufactures kits combining sterile implants and single-use instruments, available at any time to the surgeon. These technologies are part of a minimally invasive approach aimed at reducing the risk of contamination and infection, for the benefit of the patient and with a positive impact on hospitalization times and costs. Protected by 18 patent families, SteriSpineTM kits are CE marked and FDA approved. Safe Orthopaedics is headquartered in the Paris region (Eragny-sur- Oise (95610)) and has subsidiaries in the United Kingdom, Germany, the United States and the Lyon region (Fleurieux-sur-l'Arbresle).

For more information: www.safeorthopaedics.com

Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation centre and two production sites in France (Fleurieux-sur-l'Arbresle, 69210) and Tunisia, offering a wide range of industrial services: design, industrialisation, machining, finishing and sterile packaging. Supported by the French recovery plan in 2020, the company invests in additive printing and will be operational in 2022 on this new technology.

For more information: www.safemedical.fr


Safe Orthopaedics

François-Henri Reynaud

Chief Financial and Administrative Officer Tél. : +33 (0)1 34 21 50 00 investors@safeorthopaedics.com

Press Relations

Ulysse Communication

Pierre-Louis Germain / +33 (0)6 64 79 97 51 / plgermain@ulysse-communication.com Bruno Arabian / +33 (0)6 87 88 47 26 / barabian@ulysse-communication.com


Safe Orthopaedics SA published this content on 13 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 October 2021 16:01:07 UTC.

© Publicnow 2021
10/14GLOBAL MARKETS LIVE : Apple, Volkswagen, Amazon, Wisekey, Morgan Stanley...
10/13SAFE ORTHOPAEDICS : Medical inaugurates its Integrated Innovation and Production Centre (C..
10/13SAFE : Medical inaugurates its Integrated Innovation and Production Centre (CIPI) on the F..
10/07Safe Orthopaedics Announces Consolidated Sales Results for the Third Quarter and Nine M..
10/07SAFE ORTHOPAEDICS : announces consolidated sales of €1.18 million +31% in Q3 2021
10/01SAFE ORTHOPAEDICS : reports first-half 2021 financial results and announces ISO 13485 cert..
09/30SAFE : reports first-half 2021 financial results and announces ISO13485 certification of i..
07/09SAFE ORTHOPAEDICS : announces its revenues for the first half of 2021 - Corrective documen..
07/08GLOBAL MARKETS LIVE : Microsoft, Deliveroo, Didi, Biogen, Tesla...
07/07SAFE ORTHOPAEDICS : announces its revenues for the first half of 2021
More news
Sales 2021 4,87 M 5,65 M 5,65 M
Net income 2021 -7,61 M -8,82 M -8,82 M
Net Debt 2021 9,30 M 10,8 M 10,8 M
P/E ratio 2021 -
Yield 2021 -
Capitalization 16,1 M 18,6 M 18,6 M
EV / Sales 2021 5,20x
EV / Sales 2022 4,05x
Nbr of Employees 134
Free-Float 98,6%
Duration : Period :
Safe Orthopaedics Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SAFE ORTHOPAEDICS
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,33 €
Average target price 0,64 €
Spread / Average Target 92,4%
Managers and Directors
Pierre Dumouchel Chairman & Chief Executive Officer
François-Henri Reynaud Director, Chief Financial & Administrative Officer
Thomas Droulout Chief Technology Officer & Director
Ismaël Nujurally Independent Director
Philippe Chêne Independent Director
Sector and Competitors